International Assets Investment Management LLC Makes New Investment in Koninklijke Philips (NYSE:PHG)

International Assets Investment Management LLC purchased a new stake in shares of Koninklijke Philips (NYSE:PHG - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 40,851 shares of the technology company's stock, valued at approximately $953,000.

Other institutional investors have also added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. raised its stake in shares of Koninklijke Philips by 166.7% during the third quarter. Newbridge Financial Services Group Inc. now owns 1,600 shares of the technology company's stock valued at $32,000 after acquiring an additional 1,000 shares during the last quarter. Allworth Financial LP raised its stake in shares of Koninklijke Philips by 113.3% during the third quarter. Allworth Financial LP now owns 3,242 shares of the technology company's stock valued at $65,000 after acquiring an additional 1,722 shares during the last quarter. Spire Wealth Management raised its stake in shares of Koninklijke Philips by 127.2% during the third quarter. Spire Wealth Management now owns 3,446 shares of the technology company's stock valued at $69,000 after acquiring an additional 1,929 shares during the last quarter. Bruce G. Allen Investments LLC bought a new position in shares of Koninklijke Philips during the fourth quarter valued at about $140,000. Finally, PAX Financial Group LLC bought a new position in shares of Koninklijke Philips during the third quarter valued at about $199,000. 13.67% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

PHG has been the subject of several recent analyst reports. BNP Paribas downgraded shares of Koninklijke Philips from an "outperform" rating to an "underperform" rating in a research note on Wednesday, February 7th. StockNews.com raised shares of Koninklijke Philips from a "buy" rating to a "strong-buy" rating in a research note on Thursday, February 8th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Koninklijke Philips currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.00.

Koninklijke Philips Trading Up 1.9 %

PHG stock traded up $0.40 during trading on Tuesday, reaching $21.01. The company had a trading volume of 1,953,024 shares, compared to its average volume of 1,003,382. Koninklijke Philips has a 52 week low of $17.75 and a 52 week high of $24.27. The company has a market cap of $19.51 billion, a P/E ratio of -36.86, a PEG ratio of 1.03 and a beta of 0.88. The business has a 50 day moving average of $20.39 and a 200 day moving average of $20.89. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.20 and a quick ratio of 0.78.

Koninklijke Philips (NYSE:PHG - Get Free Report) last released its quarterly earnings results on Monday, January 29th. The technology company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.41 by $0.03. Koninklijke Philips had a negative net margin of 2.53% and a positive return on equity of 14.17%. The company had revenue of $5.45 billion during the quarter, compared to the consensus estimate of $5.47 billion. As a group, sell-side analysts forecast that Koninklijke Philips will post 1.53 earnings per share for the current fiscal year.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.